Matthew T. Wheeler, MD, PhD; Paul A. Heidenreich, MD, MS; Victor F. Froelicher, MD; Mark A. Hlatky, MD; Euan A. Ashley, MB ChB, DPhil
Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness.
To evaluate the cost-effectiveness of ECG plus cardiovascular-focused history and physical examination compared with cardiovascular-focused history and physical examination alone for preparticipation screening.
Decision-analysis, cost-effectiveness model.
Published epidemiologic and preparticipation screening data, vital statistics, and other publicly available data.
Competitive athletes in high school and college aged 14 to 22 years.
Nonparticipation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease.
Incremental health care cost per life-year gained.
Addition of ECG to preparticipation screening saves 2.06 life-years per 1000 athletes at an incremental total cost of $89 per athlete and yields a cost-effectiveness ratio of $42Â 900 per life-year saved (95% CI, $21Â 200 to $71Â 300 per life-year saved) compared with cardiovascular-focused history and physical examination alone. Compared with no screening, ECG plus cardiovascular-focused history and physical examination saves 2.6 life-years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76Â 100 per life-year saved ($62Â 400 to $130Â 000).
Results are sensitive to the relative risk reduction associated with nonparticipation and the cost of initial screening.
Effectiveness data are derived from 1 major European study. Patterns of causes of sudden death may vary among countries.
Screening young athletes with 12-lead ECG plus cardiovascular-focused history and physical examination may be cost-effective.
Stanford Cardiovascular Institute and the Breetwor Foundation.
Learn more about subscription options.
Register Now for a free account.
Wheeler MT, Heidenreich PA, Froelicher VF, Hlatky MA, Ashley EA. Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes. Ann Intern Med. 2010;152:276–286. doi: 10.7326/0003-4819-152-5-201003020-00005
Download citation file:
Published: Ann Intern Med. 2010;152(5):276-286.
Cardiology, Healthcare Delivery and Policy, High Value Care, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only